Preclinical News and Research

RSS
Development of children with ASD much like that of children without ASD at 6 months of age

Development of children with ASD much like that of children without ASD at 6 months of age

Study finds two distinct patterns of language, social and motor development in children with ASD

Study finds two distinct patterns of language, social and motor development in children with ASD

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

Study finds two distinct patterns of language, social and motor development in children with ASD

Study finds two distinct patterns of language, social and motor development in children with ASD

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

Ultra-high performance SPECT systems announced by MILabs

Ultra-high performance SPECT systems announced by MILabs

Botanical treatment holds hope for triple-negative breast cancer

Botanical treatment holds hope for triple-negative breast cancer

SAGE announces purchase of The Journal of International Medical Research

SAGE announces purchase of The Journal of International Medical Research

Highlights from 25th European College of Neuropsychopharmacology Congress

Highlights from 25th European College of Neuropsychopharmacology Congress

Thrasos completes $35 Million financing for development of THR-184 against AKI

Thrasos completes $35 Million financing for development of THR-184 against AKI

Exploring the New Biopharmaceutical Contract Manufacturing Offering from Olympus

Exploring the New Biopharmaceutical Contract Manufacturing Offering from Olympus

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Genzyme, Alnylam partner to develop and commercialize RNAi therapeutics against ATTR

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Ustekinumab success in refractory Crohn’s disease

Ustekinumab success in refractory Crohn’s disease

High flavonoid intake may reduce risk of highly aggressive prostate cancer

High flavonoid intake may reduce risk of highly aggressive prostate cancer

Study describes design and effectiveness of NIR responsive gold nanorods for chemotherapy

Study describes design and effectiveness of NIR responsive gold nanorods for chemotherapy

Reprogrammed endothelial cells for treatment of vascular disorders

Reprogrammed endothelial cells for treatment of vascular disorders

BioLineRx completes pre-clinical development of BL-8020 for HCV

BioLineRx completes pre-clinical development of BL-8020 for HCV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.